Showing results (171-180 of 2,408) with videos related to
Sort By:
Pageof 241
Journal of Medical Economics|June 19, 2018
Budget impact analysis of demineralized bone matrix in combination with autograft in lumbar spinal fusion procedures for the treatment of lumbar degenerative disc disease in SpainKirk Geale, María Álvarez, Maria Polyzoi, et al.Journal of Medical Economics|July 14, 2018
Understanding healthcare burden and treatment patterns among young adults with schizophreniaAhong Huang, Tony B Amos, Kruti Joshi, et al.Journal of Medical Economics|July 7, 2018
The cost of diabetes and obesity in AustraliaCrystal Man Ying Lee, Brandon Goode, Emil Nørtoft, et al.Journal of Medical Economics|June 21, 2018
When does economic model type become a decisive factor in health technology appraisals? Learning from the expanding treatment options for relapsing-remitting multiple sclerosisKathleen Mary Noon, Stephen Maxwell Montgomery, Nicholas Edward Adlard, et al.Journal of Medical Economics|April 11, 2023
Budget impact of prophylactic treatment of rVIII-SingleChain in moderate and severe hemophilia A in ItalyEugenio Di Brino, Songkai Yan, Radovan Tomic, et al.Journal of Medical Economics|April 12, 2023
Cost-effectiveness of a novel, non-active implantable device as a treatment for refractory gastro-esophageal reflux diseaseSam Harper, Lukasz Grodzicki, Stuart Mealing, et al.Journal of Medical Economics|April 17, 2023
Impact of using the International Risk Scoring Tool on the cost-utility of palivizumab for preventing severe respiratory syncytial virus infection in Canadian moderate-to-late preterm infantsBarry S Rodgers-Gray, John R Fullarton, Xavier Carbonell-Estrany, et al.Journal of Medical Economics|March 31, 2021
Treatment patterns, healthcare resource utilization, and costs of patients diagnosed with primary mediastinal B-cell lymphoma in the United StatesXiaoqin Yang, François Laliberté, Guillaume Germain, et al.Journal of Medical Economics|April 9, 2015
Budgetary impact of the utilization of buprenorphine/naloxone sublingual film and tablet for Medicaid in the United StatesCarl V Asche, Emilie Clay, Elizaveta Kharitonova, et al.Journal of Medical Economics|April 9, 2015
Cost effectiveness of paliperidone palmitate versus oral antipsychotics in patients with schizophrenia and a history of criminal justice involvementErik Muser, Chris M Kozma, Carmela J Benson, et al.Pageof 241